financetom
Business
financetom
/
Business
/
Everspin Technologies' Q3 revenue slightly beats estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Everspin Technologies' Q3 revenue slightly beats estimates
Nov 5, 2025 1:35 PM

Overview

* Everspin ( MRAM ) Q3 revenue rises 16% yr/yr to $14.1 mln, slightly beating expectations

* Company's gross margin improved to 51.3% from 49.2% in the prior year

* GAAP net income declines to $54,000 from $2.3 mln in Q3 2024

Outlook

* Everspin expects Q4 2025 revenue between $14.0 mln and $15.0 mln

* Company projects Q4 2025 GAAP EPS between $0.02 and $0.07

* Everspin anticipates Q4 2025 non-GAAP EPS between $0.08 and $0.13

Result Drivers

* APPLICATION STRENGTH - Co attributes Q3 revenue growth to strong performance in Low Earth Orbital Satellite, Casino Gaming, and Energy Management applications

* MRAM SALES - Increase in MRAM product sales contributed to revenue growth, with sales rising from $10.4 mln to $12.7 mln

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Slight $14.1 $14 mln

Revenue Beat* mln (2

Analysts

)

Q3 Gross 51.3%

Margin

Q3 $8.80

Operatin mln

g

Expenses

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the semiconductors peer group is "buy"

* Wall Street's median 12-month price target for Everspin Technologies Inc ( MRAM ) is $8.50, about 15.9% below its November 4 closing price of $9.85

* The stock recently traded at 32 times the next 12-month earnings vs. a P/E of 21 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lightspeed Commerce Up 1.2% In US Premarket As Responds to Media Reports That it is For Sale
Lightspeed Commerce Up 1.2% In US Premarket As Responds to Media Reports That it is For Sale
Oct 3, 2024
05:31 AM EDT, 09/26/2024 (MT Newswires) -- Lightspeed Commerce ( LSPD ) was at last look up near 1.3% in U.S. premarket trade on Thursday after it released a statement overnight noting recent media reports concerning a potential transaction involving the company. In the statement, Lightspeed said it periodically undertakes, and is currently conducting, a strategic review of its business...
US ports extend delivery hours as strike threat looms
US ports extend delivery hours as strike threat looms
Oct 3, 2024
Sept 25 (Reuters) - U.S. ports along the East and Gulf Coasts are extending delivery hours for importers as they rush to clear cargo ahead of a potential strike by dockworkers on Oct. 1. Ports from New York to Virginia are also working on contingency plans to avoid disruptions after some 45,000 dockworkers aligned to the International Longshoremen's Association threatened...
Golub Capital BDC Reduces Credit Facility Borrowing Capacity to $250 Million
Golub Capital BDC Reduces Credit Facility Borrowing Capacity to $250 Million
Oct 3, 2024
05:27 AM EDT, 09/26/2024 (MT Newswires) -- Golub Capital BDC ( GBDC ) said Wednesday the company and its Golub Capital BDC ( GBDC ) 4 Funding subsidiary reduced their borrowing capacity under a PNC credit facility from $400 million to $250 million. The company said the change is effective as of Thursday and other terms of the facility will...
Apimeds Pharmaceuticals Launches Initial Public Offering
Apimeds Pharmaceuticals Launches Initial Public Offering
Oct 3, 2024
05:20 AM EDT, 09/26/2024 (MT Newswires) -- Apimeds Pharmaceuticals on Wednesday filed regulatory papers for an initial public offering. The date and pricing of the offering were not disclosed. The company said it plans to trade on the New York Stock Exchange under the ticker symbol APUS. The company said Inscobee, a publicly traded company in South Korea, currently owns...
Copyright 2023-2026 - www.financetom.com All Rights Reserved